首页> 外文期刊>European Journal of Pharmacology: An International Journal >The 5-HT(1) receptors inhibiting the rat vasodepressor sensory CGRPergic outflow: further involvement of 5-HT(1F), but not 5-HT(1A) or 5-HT(1D), subtypes.
【24h】

The 5-HT(1) receptors inhibiting the rat vasodepressor sensory CGRPergic outflow: further involvement of 5-HT(1F), but not 5-HT(1A) or 5-HT(1D), subtypes.

机译:5-HT(1)受体抑制大鼠血管舒缩压感官CGRPergic流出:5-HT(1F)进一步参与,但5-HT(1A)或5-HT(1D)亚型不参与。

获取原文
获取原文并翻译 | 示例
           

摘要

We have previously shown that 5-HT(1B) receptors inhibit prejunctionally the rat vasodepressor CGRPergic sensory outflow. Since 5-HT(1) receptors comprise 5-HT(1A), 5-HT(1B), 5-HT(1D) and 5-HT(1F) functional subtypes, this study has further investigated the role of 5-HT(1A), 5-HT(1D) and 5-HT(1F) receptor subtypes in the inhibition of the above vasodepressor sensory outflow. Pithed rats were pretreated with i.v. continuous infusions of hexamethonium and methoxamine, followed by 5-HT(1) receptor agonists. Then electrical spinal stimulation (T(9)-T(12)) or i.v. bolus injections of exogenous alpha-CGRP produced frequency-dependent or dose-dependent vasodepressor responses. The electrically-induced vasodepressor responses remained unchanged during infusions of the 5-HT(1A) receptor agonists 8-OH-DPAT and NN-DP-5-CT. In contrast, these responses were inhibited by the agonists sumatriptan (5-HT(1A/1B/1D/1F)), indorenate (5-HT(1A)), PNU-142633 (5-HT(1D)) or LY344864 (5-HT(1F)), which did not affect the vasodepressor responses to exogenous CGRP (implying a prejunctional sensory-inhibition). When analysing the effects of antagonists: (i) 310 mug/kg (but not 100 mug/kg) GR127935 (5-HT(1A/1B/1D/1F)) abolished the inhibition to sumatriptan, indorenate, PNU-142633 or LY344864; (ii) 310 mug/kg SB224289 (5-HT(1B)) or BRL15572 (5-HT(1D)) failed to block the inhibition to sumatriptan or PNU-142633, whereas SB224289+BRL15572 partly blocked the inhibition to sumatriptan; and (iii) 10 mug/kg WAY100635 (5-HT(1A)) failed to block the inhibition to indorenate. These results suggest that 5-HT(1F), but not 5-HT(1A) or 5-HT(1D), receptor subtypes inhibit the vasodepressor sensory CGRPergic outflow although, admittedly, no selective 5-HT(1F) receptor agonist is available yet. The pharmacological profile of these receptors resembles that shown in rat dorsal root ganglia by molecular biology techniques.
机译:我们以前已经表明,5-HT(1B)受体可抑制大鼠血管降压药CGRPergic的感觉流出。由于5-HT(1)受体包含5-HT(1A),5-HT(1B),5-HT(1D)和5-HT(1F)功能亚型,因此本研究进一步研究了5-HT的作用(1A),5-HT(1D)和5-HT(1F)受体亚型可抑制上述血管加压素感觉外流。取髓的大鼠经静脉内预处理。连续注入六甲铵和甲氧明,然后是5-HT(1)受体激动剂。然后进行脊柱电刺激(T(9)-T(12))或i.v.大剂量外源性α-CGRP注射产生频率依赖性或剂量依赖性血管舒缩剂反应。 5-HT(1A)受体激动剂8-OH-DPAT和NN-DP-5-CT的输注过程中,电诱导的血管加压素反应保持不变。相反,激动剂舒马曲坦(5-HT(1A / 1B / 1D / 1F)),吲哚酸盐(5-HT(1A)),PNU-142633(5-HT(1D))或LY344864( 5-HT(1F)),它不影响血管舒缩剂对外源性CGRP的反应(暗示结膜感觉抑制)。分析拮抗剂的作用时:(i)310杯/千克(但不是100杯/千克)GR127935(5-HT(1A / 1B / 1D / 1F))取消了对舒马曲坦,吲哚酸酯,PNU-142633或LY344864的抑制作用; (ii)310杯/千克SB224289(5-HT(1B))或BRL15572(5-HT(1D))无法阻止对舒马曲坦或PNU-142633的抑制作用,而SB224289 + BRL15572则部分阻止对舒马曲坦的抑制作用; (iii)10马克/千克WAY100635(5-HT(1A))无法阻止抑制作用。这些结果表明,5-HT(1F)而不是5-HT(1A)或5-HT(1D)受体亚型抑制血管舒缩剂感觉CGRPergic流出,尽管公认的是,没有选择性5-HT(1F)受体激动剂可用。这些受体的药理学特征类似于通过分子生物学技术在大鼠背根神经节中显示的那些。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号